Monitoring the expression of therapeutic genes in targeted tissues in disea
se models is important to assessing the effectiveness of systems of gene th
erapy delivery. We applied a new light-detection cooled charged-coupled dev
ice (CCCD) camera for continuous in vivo assessment of commonly used gene t
herapy delivery systems (such as ex vivo manipulated cells, viral vectors,
and naked DNA), without the need to kill animals. We examined a variety of
criteria related to real-time monitoring of luciferase (luc) gene expressio
n in tissues including bone, muscle, salivary glands, dermis, liver, perito
neum, testis, teeth, prostate, and bladder in living mice and rats. These c
riteria included determination of the efficiency of infection/transfection
of various viral and nonviral delivery systems, promoter specificity, and v
isualization of luciferase activity, and of the ability of luciferin to rea
ch various organs. The exposure time for detection of luc activity by the C
CCD camera is relatively short (approximately 2 minutes) compared with the
intensified CCD camera photon-counting method (approximately 15 minutes). H
ere we transduce a variety of vectors (such as viruses, transfected cells,
and naked DNA) by various delivery methods, including electroporation, syst
emic injection of viruses, and tail-vein, high-velocity-high-volume adminis
tration of DNA plasmids. The location, intensity, and duration of luc expre
ssion in different organs were determined. The distribution of luciferin is
most probably not a barrier for the detection of in vivo luciferase activi
ty. We showed that the CCCD photon detection system is a simple, reproducib
le, and applicable method that enables the continuous monitoring of a gene
delivery system in living animals.